TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmacosweden AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
1,472
|
1,459
|
1,477 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
70
|
70
|
68 |
| EBITDA |
130
|
119
|
110 |
| Total assets |
734
|
720
|
716 |
| Current assets |
459
|
580
|
602 |
| Current liabilities |
276
|
286
|
289 |
| Equity capital |
458
|
434
|
426 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
9
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
62.4%
|
60.3%
|
59.5% |
| Turnover per employee |
164
|
162
|
164 |
| Profit as a percentage of turnover |
4.8%
|
4.8%
|
4.6% |
| Return on assets (ROA) |
9.5%
|
9.7%
|
9.5% |
| Current ratio |
166.3%
|
202.8%
|
208.3% |
| Return on equity (ROE) |
15.3%
|
16.1%
|
16.0% |
| Change turnover |
66
|
114
|
437 |
| Change turnover % |
5%
|
9%
|
42% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
29% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.